Published in Mol Cell on July 01, 1999
Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol Biol Cell (2004) 2.21
Hide and run. Arginine-based endoplasmic-reticulum-sorting motifs in the assembly of heteromultimeric membrane proteins. EMBO Rep (2005) 2.04
Defective trafficking and function of KATP channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy. Proc Natl Acad Sci U S A (2001) 1.69
Analysis of endoplasmic reticulum trafficking signals by combinatorial screening in mammalian cells. Proc Natl Acad Sci U S A (2001) 1.65
Processing and function of CFTR-DeltaF508 are species-dependent. Proc Natl Acad Sci U S A (2007) 1.62
Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms. Proc Natl Acad Sci U S A (2006) 1.56
p11, an annexin II subunit, an auxiliary protein associated with the background K+ channel, TASK-1. EMBO J (2002) 1.38
Endocytic trafficking of CFTR in health and disease. J Cyst Fibros (2006) 1.36
Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking. Traffic (2008) 1.34
Cooperative assembly and misfolding of CFTR domains in vivo. Mol Biol Cell (2009) 1.31
Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. J Clin Invest (2007) 1.29
Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate. Proc Natl Acad Sci U S A (2001) 1.26
Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation. Proc Natl Acad Sci U S A (2004) 1.19
Mechanisms of cardiac potassium channel trafficking. J Physiol (2007) 1.09
Thermally unstable gating of the most common cystic fibrosis mutant channel (ΔF508): "rescue" by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops. J Biol Chem (2011) 1.04
The cystic fibrosis transmembrane conductance regulator (CFTR): three-dimensional structure and localization of a channel gate. J Biol Chem (2011) 1.02
Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR. J Physiol (2014) 1.00
Potential for therapeutic manipulation of the UPR in disease. Semin Immunopathol (2013) 0.99
CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo. Proc Natl Acad Sci U S A (2002) 0.98
Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant. J Biol Chem (2011) 0.93
Interplay between ER exit code and domain conformation in CFTR misprocessing and rescue. Mol Biol Cell (2009) 0.89
Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulator. Expert Rev Proteomics (2010) 0.89
Role of cationic amino acids in the Na+/dicarboxylate co-transporter NaDC-1. Biochem J (2000) 0.84
Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases. Mol Biol Cell (2000) 0.84
Association with {beta}-COP regulates the trafficking of the newly synthesized Na,K-ATPase. J Biol Chem (2010) 0.83
Conformational maturation and post-ER multisubunit assembly of gap junction proteins. Mol Biol Cell (2009) 0.83
Mutations in the reduced-folate carrier affect protein localization and stability. Biochem J (2000) 0.83
Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor. Biochim Biophys Acta (2008) 0.83
Synthesis and properties of molecular probes for the rescue site on mutant cystic fibrosis transmembrane conductance regulator. J Med Chem (2011) 0.81
Cyclic AMP-Rap1A signaling mediates cell surface translocation of microvascular smooth muscle α2C-adrenoceptors through the actin-binding protein filamin-2. Am J Physiol Cell Physiol (2013) 0.81
Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis. Front Pharmacol (2012) 0.79
CFTR Folding Consortium: methods available for studies of CFTR folding and correction. Methods Mol Biol (2011) 0.79
The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator. BMC Biochem (2002) 0.78
Acid-Sensing Ion Channel 2a (ASIC2a) Promotes Surface Trafficking of ASIC2b via Heteromeric Assembly. Sci Rep (2016) 0.75
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol (2001) 7.73
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell (1995) 5.61
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell (1992) 4.71
Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60
Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science (1983) 3.88
Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene. Nature (1991) 3.61
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature (1985) 3.59
Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell (1991) 3.56
Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A (2003) 3.53
Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science (1985) 3.43
Multi-ion pore behaviour in the CFTR chloride channel. Nature (1993) 3.14
Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93
Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. J Biol Chem (1993) 2.85
The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. Proc Natl Acad Sci U S A (1998) 2.83
The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem (1993) 2.65
Mislocalization of delta F508 CFTR in cystic fibrosis sweat gland. Nat Genet (1992) 2.64
Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J (1998) 2.55
Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (1994) 2.27
Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J Gen Physiol (1997) 2.26
DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol Cell Biol (1982) 2.03
Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem (1979) 1.98
Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther (1985) 1.92
Cl- channel activity in Xenopus oocytes expressing the cystic fibrosis gene. J Biol Chem (1991) 1.86
MSP RFLP for X-linked proteolipid protein gene (PLP) identified with either rat or human PLP cDNA clone. Nucleic Acids Res (1987) 1.80
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates. J Gen Physiol (1993) 1.74
Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep (1983) 1.72
The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun (1986) 1.71
Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity. J Biol Chem (1996) 1.66
Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites. J Gen Physiol (1999) 1.61
Long QT syndrome. New electrocardiographic characteristics. Circulation (1990) 1.60
Hypoglycemia leads to age-related loss of vision. Proc Natl Acad Sci U S A (2006) 1.59
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res (1983) 1.53
A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill (2010) 1.51
Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28s-ribosomal RNA gene expression in human hepatocellular carcinoma. Hepatology (1996) 1.50
Sex differences in the transmission of migraine. Cephalalgia (2007) 1.49
[Recommendations for clinical-chemical departments: lipid-lipoprotein analysis]. Ugeskr Laeger (1990) 1.47
Regulation of CFTR ion channel gating by MgATP. FEBS Lett (1998) 1.46
Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. J Biol Chem (1994) 1.42
Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. Euro Surveill (2011) 1.40
[Hyperlipidemia in children]. Ugeskr Laeger (1993) 1.40
Differential interactions of nucleotides at the two nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (2001) 1.39
The cystic fibrosis transmembrane regulator is present and functional in endosomes. Role as a determinant of endosomal pH. J Biol Chem (1992) 1.38
Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin. Infect Control Hosp Epidemiol (2001) 1.38
The non-hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating. J Physiol (2000) 1.38
CFTR is a monomer: biochemical and functional evidence. J Membr Biol (2002) 1.38
Human fetal liver contains both zinc- and copper-rich forms of metallothionein. J Biol Chem (1980) 1.35
Phosphatase inhibitors activate normal and defective CFTR chloride channels. Proc Natl Acad Sci U S A (1994) 1.34
Frequency of recent retrotransposition events in the human factor IX gene. Hum Mutat (2001) 1.33
Dibasic protein kinase A sites regulate bursting rate and nucleotide sensitivity of the cystic fibrosis transmembrane conductance regulator chloride channel. J Physiol (1998) 1.33
Direct action of genistein on CFTR. Pflugers Arch (1997) 1.32
Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator. Biochemistry (1994) 1.32
Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrob Agents Chemother (2000) 1.29
ATPase activity of purified multidrug resistance-associated protein. J Biol Chem (1997) 1.29
Allosteric interactions between the two non-equivalent nucleotide binding domains of multidrug resistance protein MRP1. J Biol Chem (2000) 1.27
Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry (1997) 1.25
Inhibition of epithelial Na+ currents by intracellular domains of the cystic fibrosis transmembrane conductance regulator. FEBS Lett (1997) 1.24
cAMP-inducible chloride conductance in mouse fibroblast lines stably expressing the human cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci U S A (1991) 1.23
cAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue Ser-753 and its role in channel activation. J Biol Chem (1995) 1.22
Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity. J Biol Chem (1996) 1.21
Hepatitis E virus infection among domestic animals in eastern China. Zoonoses Public Health (2008) 1.21
Database and software for the analysis of mutations in the human p53 gene. Cancer Res (1994) 1.21
Phosphorylation of protein kinase C sites in NBD1 and the R domain control CFTR channel activation by PKA. J Physiol (2003) 1.19
Regulation of CFTR expression and function during differentiation of intestinal epithelial cells. EMBO J (1992) 1.18
Combination effect of vancomycin and beta-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob Agents Chemother (2001) 1.18
Variations in Immune Response of Popillia japonica and Acheta domesticus to Heterorhabditis bacteriophora and Steinernema Species. J Nematol (1994) 1.17
Phenotypic abnormalities in long-term surviving cystic fibrosis mice. Pediatr Res (1996) 1.16
School problems in Tourette's syndrome. Arch Neurol (1996) 1.16
Receptors that couple to 2 classes of G proteins increase cAMP and activate CFTR expressed in Xenopus oocytes. Receptors Channels (1993) 1.15
Bicarbonate permeability of the outwardly rectifying anion channel. J Membr Biol (1989) 1.14
Quantitation of mRNA by the kinetic polymerase chain reaction assay: a tool for monitoring P-glycoprotein gene expression. Anal Biochem (1991) 1.14
Intracellular localization of GDP-L-fucose:glycoprotein and CMP-sialic acid: apolipoprotein glycosyltransferases in rat and pork livers. Arch Biochem Biophys (1975) 1.14
Study of the expression of myelin proteolipid protein (lipophilin) using a cloned complementary DNA. Nucleic Acids Res (1985) 1.13
Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells. J Biol Chem (1993) 1.13
Interactions of lectins with membrane glycoproteins. Effects of concanavalin A on 5'-nucleotidase. Biochim Biophys Acta (1974) 1.09
The cystic fibrosis transmembrane conductance regulator chloride channel. Iodide block and permeation. Biophys J (1992) 1.08
Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae. Arch Biochem Biophys (2001) 1.08
Differential regulation of single CFTR channels by PP2C, PP2A, and other phosphatases. Am J Physiol (1998) 1.06
Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes (2001) 1.06
Molecular evolution and intragenic recombination of the merozoite surface protein MSP-3alpha from the malaria parasite Plasmodium vivax in Thailand. Parasitology (2005) 1.05
Influence of phosphorylation by protein kinase A on CFTR at the cell surface and endoplasmic reticulum. Biochim Biophys Acta (1999) 1.05